![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1468316
¾È°ú ÀÇ·á±â±â ½ÃÀå º¸°í¼ : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°(2024-2032³â)Ophthalmic Devices Market Report by Product Type, Application, End Use, and Region 2024-2032 |
¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 276¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 385¾ï ´Þ·¯¿¡ ´ÞÇØ 2024-2032³â »çÀÌ 3.7%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.
¾È°ú ÀÇ·á±â±â´Â ¿Ü°úÀû Áø´Ü ¹× ½Ã·Â ±³Á¤¿¡ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÄÜÅÃÆ®·»Áî, ÄÜÅÃÆ®·»Áî °ü¸® Á¦Ç°, Áø´Ü¾à, ÀÓÇöõÆ®, Àΰø¼öÁ¤Ã¼(IOL), ·¹ÀÌÀú, ÃÊÀ½ÆÄ À¯È ½Ã½ºÅÛ, Àΰø´«¹°, ¼ö¼ú±â±¸ µîÀ¸·Î ±¸¼ºµË´Ï´Ù. À̵éÀº ¾È±¸ ÀÌ»ó, °á¼Õ ¹× ±âŸ ¾È°ú ÁúȯÀÇ Áø´Ü ¹× Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. Ä¡·á ½Ã°£À» ´ÜÃàÇÏ°í ¾çÁúÀÇ ¾È°ú ÀǷḦ Á¦°øÇÔÀ¸·Î½á ȯÀÚ¿Í ¾È°ú Àǻ翡°Ô ¾È°ú Ä¡·á¸¦ º¸´Ù Æí¸®ÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ¹é³»Àå, ³ì³»Àå µî ¾È°ú ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î ¾È°ú ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
³ëÆ®ºÏ, ½º¸¶Æ®Æù, PC, ÀüÀÚÃ¥ ¸®´õ±â µî µðÁöÅÐ ±â±â¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö´Â °ÍÀº ½ÃÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ±Ù°Å¸® ¹× ¿ø°Å¸® ½Ã·Â ȸº¹À» À§ÇØ Àΰø¼öÁ¤Ã¼(IOL)ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÇ·á »ê¾÷ÀÇ È®Àå°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾È°ú Àü¹®°¡µé »çÀÌ¿¡¼ ¾È°ú Áúȯ ¹× °ü·Ã ÇÕº´ÁõÀ» Ä¡·áÇϱâ À§ÇÑ °í°´ ±³À° ¹× ±³À°ÀÌ ÀÌ·ç¾îÁö°í ÀÖ´Â °Íµµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀº ½Ã·Â ¿À·ù¸¦ Ä¡·áÇÏ´Â »õ·Î¿î ÀåÄ¡ °³¹ßÀ» À§ÇÑ ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¾È°ú ÀÇ·á±â±â¿¡ ´ëÇÑ °³ÀεéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °æÁõ ¹× Áߵ ³ì³»Àå Ä¡·á¸¦ À§ÇÑ ¹Ì¼¼Ä§½ÀÀû ³ì³»Àå(MIGs) ¼ö¼ú¿ë ÀÓÇöõÆ®ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ°¡ ´« °Ç°À» ÁõÁøÇϱâ À§ÇÑ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
The global ophthalmic devices market size reached US$ 27.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.
Ophthalmic devices are medical equipment used for surgical diagnosis and vision correction. They comprise contact lenses, contact lens care products, diagnostics, implants, intraocular lenses (IOLs), lasers, phacoemulsification systems, artificial tears, and surgical instruments. They are used to diagnose and cure ocular abnormalities or deficits, and other eye diseases. They aid in making the eye-treatment procedure more convenient for patients and ophthalmologists by reducing treatment time and providing high-quality eye care. At present, due to the rising prevalence of ophthalmic diseases, such as cataracts and glaucoma, there is an increase in the demand for ophthalmic devices across the globe.
The growing reliance on digital devices, such as laptops, smartphones, computers and e-readers, represents one of the key factors driving the market. Moreover, there is a rise in the utilization of intraocular lenses (IOLs) to replace the natural lens of eyes for restoring both near and distant vision. This, along with the expanding healthcare industry, is propelling the growth of the market. In addition, the growing customer training and education among eye care professionals to cure eye diseases and associated complications is positively influencing the market. Besides this, key market players are extensively investing in research and development (R&D) activities for the development of novel devices to treat vision errors. This, coupled with the rising awareness about ophthalmic devices among individuals, is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the employment of micro-invasive glaucoma (MIGs) surgical implants for the treatment of mild to moderate glaucoma. In line with this, governments of several countries are undertaking initiatives to promote eye health, which is bolstering the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global ophthalmic devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application and end use.
Surgical
Implants
Consumables
Equipment
Vision Care
Contact Lens
Ocular Health
Cataract
Vitreo Retinal Disorders
Glaucoma
Refractor Disorders
Hospitals and Eye Clinics
Academic and Research Laboratory
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch & Lomb Incorporated (Bausch Health Companies Inc.), Carl Zeiss Meditec AG, EssilorLuxottica SA, Haag-Streit Group, HOYA Surgical Optics GmbH (Hoya Corporation), Leica Microsystems GmbH (Danaher Corporation), Nidek Co Ltd., Topcon Corporation, Volk Optical Inc. and Ziemer Ophthalmic Systems AG.